Login to Your Account

Financings Roundup

OPKO Boosts Drug, Diagnostic Work, Adds $101M in Offering

By Jennifer Boggs

Thursday, March 10, 2011
Taking advantage of a recent stock bump, multi-focused drug and diagnostic firm OPKO Health Inc. is raising $101.3 million in a public stock sale of 27 million shares priced at $3.75 apiece.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription